BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 30002193)

  • 1. Tumor Suppressor Activity of Selenbp1, a Direct Nkx2-1 Target, in Lung Adenocarcinoma.
    Caswell DR; Chuang CH; Ma RK; Winters IP; Snyder EL; Winslow MM
    Mol Cancer Res; 2018 Nov; 16(11):1737-1749. PubMed ID: 30002193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An NKX2-1/ERK/WNT feedback loop modulates gastric identity and response to targeted therapy in lung adenocarcinoma.
    Zewdu R; Mehrabad EM; Ingram K; Fang P; Gillis KL; Camolotto SA; Orstad G; Jones A; Mendoza MC; Spike BT; Snyder EL
    Elife; 2021 Apr; 10():. PubMed ID: 33821796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homeobox Transcription Factor NKX2-1 Promotes
    Harada M; Sakai S; Ohhata T; Kitagawa K; Mikamo M; Nishimoto K; Uchida C; Niida H; Kotake Y; Sugimura H; Suda T; Kitagawa M
    Mol Cancer Res; 2017 Oct; 15(10):1388-1397. PubMed ID: 28634225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FoxA1 and FoxA2 drive gastric differentiation and suppress squamous identity in NKX2-1-negative lung cancer.
    Camolotto SA; Pattabiraman S; Mosbruger TL; Jones A; Belova VK; Orstad G; Streiff M; Salmond L; Stubben C; Kaestner KH; Snyder EL
    Elife; 2018 Nov; 7():. PubMed ID: 30475207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LKB1 loss by alteration of the NKX2-1/p53 pathway promotes tumor malignancy and predicts poor survival and relapse in lung adenocarcinomas.
    Tsai LH; Chen PM; Cheng YW; Chen CY; Sheu GT; Wu TC; Lee H
    Oncogene; 2014 Jul; 33(29):3851-60. PubMed ID: 23995788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of lung adenocarcinoma progression by Nkx2-1.
    Winslow MM; Dayton TL; Verhaak RG; Kim-Kiselak C; Snyder EL; Feldser DM; Hubbard DD; DuPage MJ; Whittaker CA; Hoersch S; Yoon S; Crowley D; Bronson RT; Chiang DY; Meyerson M; Jacks T
    Nature; 2011 May; 473(7345):101-4. PubMed ID: 21471965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NKX2-1-mediated p53 expression modulates lung adenocarcinoma progression via modulating IKKβ/NF-κB activation.
    Chen PM; Wu TC; Cheng YW; Chen CY; Lee H
    Oncotarget; 2015 Jun; 6(16):14274-89. PubMed ID: 25881545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of cellular identity in common pre-clinical models of serine‑threonine kinase 11 (Liver kinase B1) loss.
    Karthikeyan SK; Gimbrone NT; Percy TR; Cress WD
    Cancer Treat Res Commun; 2021; 26():100286. PubMed ID: 33338855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The function and significance of SELENBP1 downregulation in human bronchial epithelial carcinogenic process.
    Zeng GQ; Yi H; Zhang PF; Li XH; Hu R; Li MY; Li C; Qu JQ; Deng X; Xiao ZQ
    PLoS One; 2013; 8(8):e71865. PubMed ID: 23977169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased selenium-binding protein 1 in esophageal adenocarcinoma results from posttranscriptional and epigenetic regulation and affects chemosensitivity.
    Silvers AL; Lin L; Bass AJ; Chen G; Wang Z; Thomas DG; Lin J; Giordano TJ; Orringer MB; Beer DG; Chang AC
    Clin Cancer Res; 2010 Apr; 16(7):2009-21. PubMed ID: 20332323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription start site-level expression of thyroid transcription factor 1 isoforms in lung adenocarcinoma and its clinicopathological significance.
    Sano K; Hayashi T; Suehara Y; Hosoya M; Takamochi K; Kohsaka S; Kishikawa S; Kishi M; Saito S; Takahashi F; Kaneko K; Suzuki K; Yao T; Ishijima M; Saito T
    J Pathol Clin Res; 2021 Jul; 7(4):361-374. PubMed ID: 34014042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Foxa2 and Cdx2 cooperate with Nkx2-1 to inhibit lung adenocarcinoma metastasis.
    Li CM; Gocheva V; Oudin MJ; Bhutkar A; Wang SY; Date SR; Ng SR; Whittaker CA; Bronson RT; Snyder EL; Gertler FB; Jacks T
    Genes Dev; 2015 Sep; 29(17):1850-62. PubMed ID: 26341558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occludin is a direct target of thyroid transcription factor-1 (TTF-1/NKX2-1).
    Runkle EA; Rice SJ; Qi J; Masser D; Antonetti DA; Winslow MM; Mu D
    J Biol Chem; 2012 Aug; 287(34):28790-801. PubMed ID: 22761434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selenium-binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non-small cell lung cancer.
    Zhu Y; Pu Q; Zhang Q; Liu Y; Ma Y; Yuan Y; Liu L; Zhu W
    Cancer Med; 2023 Aug; 12(16):17149-17170. PubMed ID: 37606338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Encapsulated miR-200c and Nkx2.1 in a nuclear/mitochondria transcriptional regulatory network of non-metastatic and metastatic lung cancer cells.
    D'Almeida O; Mothar O; Bondzie EA; Lieumo Y; Tagne L; Gupta S; Volkert T; Levine S; Tagne JB
    BMC Cancer; 2019 Feb; 19(1):136. PubMed ID: 30744585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conditional Ror1 knockout reveals crucial involvement in lung adenocarcinoma development and identifies novel HIF-1α regulator.
    Isomura H; Taguchi A; Kajino T; Asai N; Nakatochi M; Kato S; Suzuki K; Yanagisawa K; Suzuki M; Fujishita T; Yamaguchi T; Takahashi M; Takahashi T
    Cancer Sci; 2021 Apr; 112(4):1614-1623. PubMed ID: 33506575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Lineage-Defining Transcription Factors SOX2 and NKX2-1 Determine Lung Cancer Cell Fate and Shape the Tumor Immune Microenvironment.
    Mollaoglu G; Jones A; Wait SJ; Mukhopadhyay A; Jeong S; Arya R; Camolotto SA; Mosbruger TL; Stubben CJ; Conley CJ; Bhutkar A; Vahrenkamp JM; Berrett KC; Cessna MH; Lane TE; Witt BL; Salama ME; Gertz J; Jones KB; Snyder EL; Oliver TG
    Immunity; 2018 Oct; 49(4):764-779.e9. PubMed ID: 30332632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced selenium-binding protein 1 in breast cancer correlates with poor survival and resistance to the anti-proliferative effects of selenium.
    Zhang S; Li F; Younes M; Liu H; Chen C; Yao Q
    PLoS One; 2013; 8(5):e63702. PubMed ID: 23704933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-206 suppresses TGF-β signalling to limit tumor growth and metastasis in lung adenocarcinoma.
    Watt K; Newsted D; Voorand E; Gooding RJ; Majewski A; Truesdell P; Yao B; Tuschl T; Renwick N; Craig AW
    Cell Signal; 2018 Oct; 50():25-36. PubMed ID: 29935234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TTF-1/Nkx2.1 functional connection with mutated EGFR relies on LRIG1 and β-catenin pathways in lung cancer cells.
    Zamboni M; Civitareale D
    Biochem Biophys Res Commun; 2018 Nov; 505(4):1027-1031. PubMed ID: 30314701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.